share_log

Electromed (NYSE:ELMD) Receives New Coverage From Analysts at StockNews.com

Defense World ·  Nov 22, 2022 04:51

StockNews.com assumed coverage on shares of Electromed (NYSE:ELMD – Get Rating) in a research report report published on Monday morning. The firm issued a strong-buy rating on the stock.

ELMD has been the topic of a number of other research reports. Lake Street Capital started coverage on Electromed in a research report on Friday, August 5th. They issued a buy rating and a $20.00 target price on the stock. EF Hutton Acquisition Co. I assumed coverage on Electromed in a research note on Tuesday, September 6th. They set a buy rating and a $13.50 price objective on the stock.

Get Electromed alerts:

Electromed Stock Up 3.7 %

Shares of ELMD opened at $10.36 on Monday. Electromed has a twelve month low of $8.75 and a twelve month high of $13.46. The stock has a market capitalization of $87.90 million, a P/E ratio of 47.09 and a beta of 0.49. The company has a 50 day moving average of $10.50 and a 200-day moving average of $10.38.

Electromed (NYSE:ELMD – Get Rating) last issued its quarterly earnings results on Tuesday, August 23rd. The company reported $0.04 earnings per share (EPS) for the quarter. Electromed had a net margin of 4.60% and a return on equity of 5.73%. The firm had revenue of $11.27 million for the quarter.

Electromed Company Profile

(Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Electromed (ELMD)
  • Three Ways To Win The Online Gambling Industry
  • Santa Claus Rally? Here's What Needs to Happen
  • Is Ardelyx is A Buy After Slip in Early 2022
  • Will the Return of Bob Iger Return the Magic to Disney Stock?
  • Is Tesla A Bargain Now As It Trades At Two-Year Lows?

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment